The new generation of messenger RNA (mRNA) vaccines against influenzaReview Published on 2023-05-012023-07-10 Journal: Enfermedades infecciosas y microbiologia clinica ( [Category] COVID19(2023년), [키워드] Eficacia vacunal flu Gripe Messenger RNA vaccines vaccine efficacy Vacunas ARN mensajero. [DOI] 10.1016/j.eimce.2022.07.006 PMC 바로가기 [Article Type] Review
Clinical efficacy and effectiveness of alternative varicella vaccination strategies: An overview of reviewsReview Published on 2023-01-012023-05-31 Journal: Reviews in Medical Virology [Category] Fulltext, 두창, 수두, 홍역, [키워드] Chickenpox immunisation overview of reviews vaccine effectiveness vaccine efficacy varicella. [DOI] 10.1002/rmv.2407 PMC 바로가기 [Article Type] Review
Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic reviewArticle Published on 2023-01-012023-07-11 Journal: Expert review of vaccines [Category] COVID19(2023년), [키워드] coronavirus COVID vaccines number of doses vaccination vaccine efficacy vaccine platforms. [DOI] 10.1080/14760584.2023.2156861 PMC 바로가기
Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy새로운 SARS-CoV-2 변종인 Omicron: 중증도 및 백신 효능에 대한 영향 평가Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Comment COVID-19 COVID-19 vaccine distribution Efficacy India Mild new SARS-CoV-2 omicron rising RT-PCR testing SARS-CoV-2 severity Vaccine vaccine candidate vaccine efficacy vaccine efficacy. Vaccine hesitancy variant variant of SARS-CoV-2 [DOI] 10.1080/21645515.2022.2034458 PMC 바로가기 [Article Type] Article
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial재조합 인터페론 무장 융합 단백질 백신(V-01)을 사용한 SARS-CoV-2에 대한 이종 부스팅의 효능: 무작위, 이중 맹검 및 위약 대조 3상 시험Clinical Trial Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 임상, 진단, [키워드] adverse event antibody assigned booster clinical trial common adverse event conducted COVID-19 vaccine COVID-19 vaccines dose double-blind dramatic increase Efficacy elicit eligible fatigue Fever fusion protein groups headache healthy Heterologous heterologous boosting Humoral immunity Identifier Immunity inactivated Inactivated vaccine Inactivated Vaccines Inc injection injection site intention-to-treat principle Malaysia Mild-to-moderate Neutralizing Neutralizing antibodies occurred Older omicron Omicron variant over Pain participant Participants Placebo placebo-controlled primary endpoint Randomized Randomly receive regimen robust Safe SARS-CoV-2 SARS-COV-2 infection second dose Serious Adverse Events subunit Subunit vaccine Subunit vaccine. Surveillance symptomatic SARS-CoV-2 infection the epidemic titre Trial Trial registration V-01 Vaccine vaccine efficacy variant virus-neutralizing antibodies was measured were assessed [DOI] 10.1080/22221751.2022.2088406 PMC 바로가기 [Article Type] Clinical Trial
Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccinesArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Ad26.COV2.S Ad26.COV2.S vaccine antibody B.1.1.529 B.1.1.7 B.1.351 B.1.617.2 Beta BNT162b2 BNT162b2 vaccine booster center contributed Control COVID-19 Delta dose Effectiveness elicited faster FIVE Gamma immunization moderate mRNA-1273 mRNA-based vaccine Mutation Neutralizing Neutralizing antibodies neutralizing antibody omicron P.1 postvaccination prevention Protein pseudovirus receiving recipient recommendation robust SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 variant subject Support vaccination Vaccine vaccine efficacy variants of concern variants of concern (VOCs). VoC VOCs wild type [DOI] 10.1002/jmv.28032 PMC 바로가기
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutionsSARS-CoV-2의 델타 변종(B.1.617.2): 돌연변이, 영향, 과제 및 가능한 솔루션Review Published on 2022-11-302022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] ACE2 acquisition Alpha B.1.617.2 Beta Characteristics COVID-19 COVID-19 pandemic Critical D614G Delta delta variant Efficacy effort Evidence Evolution explained immune evasion L452R measure Mutation omicron Omicron variant outbreak Outbreaks P681R reason for S-protein SARS-CoV-2 SARS-CoV-2 variant spike mutation spike mutations T478K the WHO Transmissibility vaccination vaccination. Vaccine vaccine efficacy VoC [DOI] 10.1080/21645515.2022.2068883 PMC 바로가기 [Article Type] Review
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studiesArticle Published on 2022-11-302023-07-10 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), [키워드] Coadministration COVID-19 vaccines influenza vaccines patient acceptance of healthcare patient compliance patient safety vaccine efficacy vaccine immunogenicity. [DOI] 10.1080/21645515.2022.2131166 PMC 바로가기
Research progress on vaccine efficacy against SARS-CoV-2 variants of concern우려되는 SARS-CoV-2 변이체에 대한 백신 효능 연구 진행Review Published on 2022-11-302022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus addition caused contributed coronavirus COVID-19 COVID-19 vaccine declined Delta Efficacy Epidemic epidemic wave Epidemics Health Organization Immune escape Measures Neutralizing Neutralizing antibodies omicron Omicron variants pathogenicity Prevention and control Protective Research research and development SARS-CoV-2 SARS-CoV-2 variant severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 triggered vaccination Vaccine vaccine efficacy variant Variant of concern. variants variety VoC VOCs WHO World Health Organization [DOI] 10.1080/21645515.2022.2057161 PMC 바로가기 [Article Type] Review
Metabolic syndrome and aberrant immune responses to viral infection and vaccination: Insights from small animal modelsReview Published on 2022-11-302023-06-14 Journal: Frontiers in Immunology [Category] Fulltext, 신종인플루엔자, [키워드] dyslipidemia hypertension metabolic syndrome obesity type 2 diabetes vaccination vaccine efficacy Viral infection. [DOI] 10.3389/fimmu.2022.1015563 PMC 바로가기 [Article Type] Review